|
Market Closed -
Nasdaq
04:00:00 06/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.260 USD | -5.26% |
|
-14.29% | -82.31% |
| 08-27 | Scinai Immunotherapeutics Ltd., H1 2026 Earnings Call, Aug 26, 2026 | |
| 08-24 | Scinai Immunotherapeutics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 718K 641K 597K 543K 1.02M 69.17M 1.03M 7.21M 2.81M 35.3M 2.7M 2.64M 113M | P/E 2024 * |
-
| P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.32M 1.18M 1.1M 1M 1.89M 128M 1.9M 13.3M 5.17M 65.09M 4.97M 4.86M 209M | EV / Sales 2024 |
4,521,658x | EV / Sales 2025 | 2,346,086x |
| Free-Float |
0.36% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SCNI | Delayed | |
CBOE
| SCNI | Real-time | |
|
Deutsche Boerse AG
| 2F50 | Delayed |
Last Transcript: Scinai Immunotherapeutics Ltd.
| 1 day | -5.26% | ||
| 1 week | -14.29% | ||
| Current month | -11.27% | ||
| 1 month | -32.26% | ||
| 3 months | -53.40% | ||
| 6 months | -79.00% | ||
| Current year | -82.31% |
| 1 week | 1.26 |  | 1.45 |
| 1 month | 1.26 | | 2.67 |
| Current year | 1.26 | | 11.2 |
| 1 year | 1.26 | | 16.3 |
| 3 years | 1.26 | | 89.2 |
| 5 years | 1.26 | | 3,490 |
| 10 years | 1.26 | | 61,999.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 51 | 02/03/2021 |
Uri Ben-Or
DFI | Director of Finance/CFO | 55 | 01/01/2007 |
Dalit Fischer
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Germain
CHM | Chairman | 77 | 30/09/2019 |
Samuel Moed
BRD | Director/Board Member | 64 | 24/03/2020 |
Adi Raviv
BRD | Director/Board Member | 71 | 24/03/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/3/26 | Other | Chief Financial Officer | 35,848,348 | 1.0507% | ||
| 18/3/26 | Other | Director | 57,400,000 | 1.6823% | ||
| 18/3/26 | Other | Director | 60,400,000 | 1.7702% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.26% | -14.29% | -90.53% | -98.20% | 718K | |
| +4.16% | +3.42% | +49.37% | +94.17% | 74.31B | |
| +1.55% | -2.76% | +21.36% | +76.43% | 56.95B | |
| +2.71% | +0.92% | +5.78% | +37.39% | 48.3B | |
| +0.50% | +2.94% | +344.62% | +722.17% | 44.51B | |
| +3.05% | -1.80% | +28.78% | +34.51% | 43.8B | |
| +1.00% | -1.46% | +5.17% | +111.90% | 41.12B | |
| -0.54% | +2.41% | +9.31% | +58.85% | 31.07B | |
| +4.24% | +7.94% | +37.50% | +32.15% | 28.97B | |
| +0.76% | -1.45% | -7.44% | -11.12% | 24.53B | |
| Average | +1.22% | -1.57% | +40.39% | +105.83% | 39.36B | |
| Weighted average by Cap. | +2.16% | -0.46% | +58.87% | +136.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.66 0.59 0.55 0.5 0.94 63.37 0.94 6.61 2.57 32.34 2.47 2.42 103.96 | 1.31 1.17 1.09 0.99 1.87 126.26 1.88 13.17 5.12 64.44 4.92 4.82 207.13 |
| Net income | 4.8M 4.28M 3.99M 3.63M 6.83M 462M 6.88M 48.16M 18.74M 236M 18M 17.62M 758M | -8.31M -7.41M -6.9M -6.28M -11.83M -800M -11.92M -83.42M -32.46M -408M -31.18M -30.51M -1.31B |
| Net Debt | 122K 109K 101K 92.27K 174K 11.75M 175K 1.23M 477K 6M 458K 448K 19.28M | 606K 541K 504K 458K 863K 58.36M 870K 6.09M 2.37M 29.79M 2.27M 2.23M 95.75M |
Employees
45
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | US$1.260 | -5.26% | 42,256 |
| 02/10/26 | US$1.330 | +1.53% | 22,168 |
| 01/10/26 | US$1.310 | -7.75% | 43,751 |
| 30/09/26 | US$1.420 | +0.71% | 80,134 |
| 29/09/26 | US$1.410 | -4.08% | 98,629 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCNI Stock
Select your edition
All financial news and data tailored to specific country editions
